Literature DB >> 16791025

Seroreversion of HIV antibodies in patients with prolonged suppression of viraemia under HAART.

Aranzazu Amor1, Carlos Toro, Victoria Jiménez, Ainhoa Simón, Belén Ramos, Vincent Soriano.   

Abstract

Prolonged virus suppression in chronically HIV-infected patients could hypothetically lead to antibody seroreversion. Eighty-four HIV-positive individuals with undetectable viraemia for longer than 5 years under HAART were examined. Only one individual, who had initiated HAART shortly after primary HIV infection, showed seroreversion. In contrast, the cure of hepatitis C virus (HCV) with interferon in 25 controls led to the loss of HCV antibodies in most cases. This information indirectly reflects that whereas HCV may be eradicable HIV is not.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16791025     DOI: 10.1097/01.aids.0000233584.10209.43

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  9 in total

1.  Brief Report: Impact of Early Antiretroviral Therapy on the Performance of HIV Rapid Tests and HIV Incidence Assays.

Authors:  Jessica M Fogel; Estelle Piwowar-Manning; Barbara Debevec; Tamara Walsky; Katherine Schlusser; Oliver Laeyendecker; Ethan A Wilson; Marybeth McCauley; Theresa Gamble; Gerald Tegha; Dean Soko; Johnstone Kumwenda; Mina C Hosseinipour; Ying Q Chen; Myron S Cohen; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-01       Impact factor: 3.731

2.  Decreased specificity of an assay for recent infection in HIV-1-infected patients on highly active antiretroviral treatment: implications for incidence estimates.

Authors:  Antoine Chaillon; Stéphane Le Vu; Sylvie Brunet; Guillaume Gras; Frédéric Bastides; Louis Bernard; Laurence Meyer; Francis Barin
Journal:  Clin Vaccine Immunol       Date:  2012-06-20

3.  Decreased Seroreactivity in Individuals Initiating Antiretroviral Therapy during Acute HIV Infection.

Authors:  Mark M Manak; Linda L Jagodzinski; Ashley Shutt; Jennifer A Malia; Mike Leos; Jason Ouellette; Siriwat Akapirat; Donn L Colby; Nittaya Phanuphak; Leigh Anne Eller; Merlin L Robb; Mark de Souza; Jintanat Ananworanich; Sheila A Peel
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

4.  longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients.

Authors:  P Randhawa; D Bohl; D Brennan; K Ruppert; B Ramaswami; G Storch; J March; R Shapiro; R Viscidi
Journal:  Clin Vaccine Immunol       Date:  2008-08-27

5.  Prolonged Posttreatment Virologic Control and Complete Seroreversion After Advanced Human Immunodeficiency Virus-1 Infection.

Authors:  Analia Uruena; Isabel Cassetti; Neena Kashyap; Claire Deleage; Jacob D Estes; Christopher Trindade; Dima A Hammoud; Peter D Burbelo; Ven Natarajan; Robin Dewar; Hiromi Imamichi; Addison J Ward; April Poole; Alexander Ober; Catherine Rehm; Sara Jones; C Jason Liang; Tae-Wook Chun; Avindra Nath; H Clifford Lane; Bryan R Smith; Mark Connors; Stephen A Migueles
Journal:  Open Forum Infect Dis       Date:  2020-12-15       Impact factor: 3.835

6.  High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease.

Authors:  Jörg Schüpbach; Leslie R Bisset; Stephan Regenass; Philippe Bürgisser; Meri Gorgievski; Ingrid Steffen; Corinne Andreutti; Gladys Martinetti; Cyril Shah; Sabine Yerly; Thomas Klimkait; Martin Gebhardt; Franziska Schöni-Affolter; Martin Rickenbach; J Barth; M Battegay; E Bernascon; J Böni; H C Bucher; P Bürgisser; C Burton-Jeangros; A Calmy; M Cavassini; R Dubs; M Egger; L Elzi; J Fehr; M Fischer; M Flepp; P Francioli; H Furrer; C A Fux; M Gorgievski; H Günthard; B Hasse; H H Hirsch; B Hirschel; I Hösli; C Kahlert; L Kaiser; O Keiser; C Kind; T Klimkait; H Kovari; B Ledergerber; G Martinetti; B Martinez de Tejada; N Müller; D Nadal; G Pantaleo; A Rauch; S Regenass; M Rickenbach; C Rudin; P Schmid; D Schultze; F Schöni-Affolter; J Schüpbach; R Speck; P Taffé; A Telenti; A Trkola; P Vernazza; V von Wyl; R Weber; S Yerly
Journal:  BMC Infect Dis       Date:  2011-09-26       Impact factor: 3.090

7.  Helios expressing regulatory T cells are correlated with decreased IL-2 producing CD8 T cells and antibody diversity in Mozambican individuals living chronically with HIV-1.

Authors:  Raquel Matavele Chissumba; Cacildo Magul; Rosa Macamo; Vânia Monteiro; Maria Enosse; Ivalda Macicame; Victória Cumbane; Nilesh Bhatt; Edna Viegas; Michelle Imbach; Leigh Anne Eller; Christina S Polyak; Luc Kestens
Journal:  BMC Immunol       Date:  2022-03-14       Impact factor: 3.615

8.  Influence of Combination Antiretroviral Therapy on HIV-1 Serological Responses and Their Implications: A Systematic Review and Meta-Analysis.

Authors:  Yuanhao Liang; Hongqing Lin; Emmanuel Enoch Dzakah; Shixing Tang
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

Review 9.  Translational HIV-1 research: from routine diagnostics to new virology insights in Amsterdam, the Netherlands during 1983-2013.

Authors:  Antoinette C van der Kuyl; Margreet Bakker; Suzanne Jurriaans; Nicole K T Back; Alexander O Pasternak; Marion Cornelissen; Ben Berkhout
Journal:  Retrovirology       Date:  2013-08-28       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.